{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.84","value":"19.5"},{"groupId":"OG001","spread":"27.51","value":"39.8"},{"groupId":"OG002","spread":"34.25","value":"58"},{"groupId":"OG003","spread":"28.38","value":"54"},{"groupId":"OG004","spread":"46.55","value":"66.9"},{"groupId":"OG005","spread":"36.6","value":"63.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"53"},{"groupId":"OG005","value":"18"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG000","title":"20 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG001","title":"30 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG002","title":"40 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG003","title":"45 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG004","title":"60 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG005","title":"80 mg"}],"paramType":"MEAN","populationDescription":"Pharmacokinetic set: Pharmacokinetic population consisted of all patients who provided at least one postdose PK plasma sample.","reportingStatus":"POSTED","timeFrame":"Day 1","title":"Maximum Plasma Concentration of Panobinostat After the First Dose in Arms 1 and 2","type":"SECONDARY","unitOfMeasure":"ng/mL"}